Abstract
Physical interaction of T cells and dendritic cells (DCs) is essential for T cell proliferation and differentiation, but it has been unclear how this interaction is regulated physiologically. Here we show that DCs produce thromboxane A2 (TXA2), whereas naive T cells express the thromboxane receptor (TP). In vitro, a TP agonist enhances random cell movement (chemokinesis) of naive but not memory T cells, impairs DC–T cell adhesion, and inhibits DC-dependent proliferation of T cells. In vivo, immune responses to foreign antigens are enhanced in TP-deficient mice, which also develop marked lymphadenopathy with age. Similar immune responses were seen in wild-type mice treated with a TP antagonist during the sensitization period. Thus, TXA2-TP signaling modulates acquired immunity by negatively regulating DC–T cell interactions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Grabbe, S. & Schwarz, T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol. Today 19, 37–44 (1998).
Lanzavecchia, A. & Sallusto, F. Regulation of T cell immunity by dendritic cells. Cell 106, 263–266 (2001).
Paul, W.E. & Seder, R.A. Lymphocyte responses and cytokines. Cell 76, 241–251 (1994).
Monks, C.R., Freiberg, B.A., Kupfer, H., Sciaky, N. & Kupfer, A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395, 82–86 (1998).
Grakoui, A. et al. The immunological synapse: a molecular machine controlling T cell activation. Science 285, 221–227 (1999).
Iezzi, G., Karjalainen, K. & Lanzavecchia, A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8, 89–95 (1998).
Narumiya, S., Sugimoto, Y. & Ushikubi, F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79, 1193–1226 (1999).
FitzGerald, G.A., Healy, C. & Daugherty, J. Thromboxane A2 biosynthesis in human disease. Fed. Proc. 46, 154–158 (1987).
Namba, T. et al. Mouse thromboxane A2 receptor: cDNA cloning, expression and northern blot analysis. Biochem. Biophys. Res. Commun. 184, 1197–1203 (1992).
Ushikubi, F. et al. Thromboxane A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J. Exp. Med. 178, 1825–1830 (1993).
Murota, S., Kawamura, M. & Morita, I. Transformation of arachidonic acid into thromboxane B2 by the homogenates of activated macrophages. Biochim. Biophys. Acta 528, 507–511 (1978).
Nüsing, R. & Ullrich, V. Immunoquantitation of thromboxane synthase in human tissues. Eicosanoids 3, 175–180 (1990).
Tone, Y. et al. Abundant expression of thromboxane synthase in rat macrophages. FEBS Lett. 340, 241–244 (1994).
Brune, K., Glatt, M., Kalin, H. & Peskar, B.A. Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature 274, 261–263 (1978).
Nüsing, R. et al. Localization of thromboxane synthase in human tissues by monoclonal antibody Tü 300. Virchows Arch. A Pathol. Anat. Histopathol. 421, 249–254 (1992).
Morinelli, T.A. et al. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist. J. Pharmacol. Exp. Ther. 251, 557–562 (1989).
Thomas, D.W. et al. Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2 . J. Clin. Invest. 102, 1994–2001 (1998).
Kouzan, S. et al. Stimulation of arachidonic acid metabolism by adherence of alveolar macrophages to a plastic substrate. Modulation by fetal bovine serum. Am. Rev. Respir. Dis. 137, 38–43 (1988).
Truneh, A., Albert, F., Golstein, P. & Schmitt-Verhulst, A.M. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313, 318–320 (1985).
Al-Alwan, M., Rowden, G., Lee, T.D.G. & West, K.A. The dendritic cell cytoskeleton is critical for the formation of the immunological synapse. J. Immunol. 166, 1452–1456 (2001).
Lanzavecchia, A. & Sallusto, F. Antigen decoding by T lymphocytes: from synapses to fate determination. Nat. Immunol. 2, 487–492 (2001).
Zheng, L. et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377, 348–351 (1995).
Inaba, K. & Steinman, R.M. Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leukocyte reaction after the antigen-dependent clustering of dendritic cells and T lymphocytes. J. Exp. Med. 165, 1403–1417 (1987).
Katagiri, K., Hattori, M., Minato, N. & Kinashi, T. Rap1 functions as a key regulator of T-cell and antigen-presenting cell interactions and modulates T-cell responses. Mol. Cell. Biol. 22, 1001–1015 (2002).
Bromley, S.K., Peterson, D.A., Gunn, M.D. & Dustin, M.L. Hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. J. Immunol. 165,15–19 (2000).
Krummel, M.F. & Davis, M.M. Dynamics of the immunological synapse: finding, establishing and solidifying a connection. Curr. Opin. Immunol. 14, 66–74 (2002).
Allen, P.M. & Unanue, E.R. Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J. Immunol. 132, 1077–1079 (1984).
Lombard-Platlet, S., Bertolino, P., Deng, H., Gerlier, D. & Rabourdin-Combe, C. Inhibition of chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell. Immunology 80, 566–573 (1993).
Kurimoto, I. et al. Studies of contact hypersensitivity induction in mice with optimal sensitizing doses of hapten. J. Invest. Dermatol. 101, 132–136 (1993).
Hanasaki, K. & Arita, H. Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in platelets. Thromb. Res. 50, 365–376 (1988).
Nagai, H. et al. Different role of IL-4 in the onset of hapten-induced contact hypersensitivity in BALB/c and C57BL/6 mice. Br. J. Pharmacol. 129, 299–306 (2000).
Ogletree, M.L. Overview of physiological and pathophysiological effects of thromboxane A2 . Fed Proc. 46, 133–138 (1987).
Daniel, T.O., Liu, H., Morrow, J.D., Crews, B.C. & Marnett, L.J. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 59, 4574–4577 (1999).
Dustin, M.L. & Cooper, J.A. The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat. Immunol. 1, 23–29 (2000).
Dustin, M.L. et al. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 94, 667–677 (1998).
Wülfing, C., Sjaastad, M.D. & Davis, M.M. Visualizing the dynamics of T cell activation: Intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc. Natl. Acad. Sci. USA 95, 6302–6307 (1998).
Bleijs, D.A., Geijtenbeek, T.B., Figdor, C.G. & van Kooyk, Y. DC-SIGN and LFA-1: a battle for ligand. Trends. Immunol. 22, 457–463 (2001).
Yong, K. & Khwaja, A. Leucocyte cellular adhesion molecules. Blood Rev. 4, 211–225 (1990).
Cifone, M.G. et al. Effect of hrTNF α on TxB2 release by macrophages. Int. J. Tissue React. 9, 51–53 (1987).
Conti, P. et al. In vitro enhanced thromboxane B2 release by polymorphonuclear leukocytes and macrophages after treatment with human recombinant interleukin 1. Prostaglandins 32, 111–115 (1986).
Goldstein, I.M. et al. Thromboxane generation by human peripheral blood polymorphonuclear leukocytes. J. Exp. Med. 148, 787–792 (1978).
Sun, L.K., Wahl, P., Bilic, G. & Wuthrich, R.P. CD44-mediated cyclooxygenase-2 expression and thromboxane A2 production in RAW 264.7 macrophages. Inflamm. Res. 50, 496–499 (2001).
Wrenger, S. et al. Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor. J. Biol. Chem. 275, 22180–22186 (2000).
Mitsuhashi, M. et al. Necessity of thromboxane A2 for initiation of platelet-mediated contact sensitivity: dual activation of platelets and vascular endothelial cells. J. Immunol. 166, 617–623 (2001).
Kabashima, K. et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109, 883–893 (2002).
Kweon, M.N., Yamamoto, M., Kajiki, M., Takahashi, I. & Kiyono, H. Systemically derived large intestinal CD4+TH2 cells play a central role in STAT6-mediated allergic diarrhea. J. Clin. Invest. 106, 199–206 (2000).
Acknowledgements
We thank Y. Kataoka for injection of embryonic stem cells; T. Furuyashiki, Y. Arakawa, H. Bito, M. Hirashima, N. Minato, Y. Miyachi, J. Cyster and S. Nishikawa for helpful discussion; K. Deguchi and T. Fujiwara for animal breeding; and T. Arai for secretarial assistance. This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan and from the Organization for Pharmaceutical Safety and Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
This work was supported in part by a grant from Ono Pharmaceutical Co. Ltd., Osaka, Japan.
Rights and permissions
About this article
Cite this article
Kabashima, K., Murata, T., Tanaka, H. et al. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat Immunol 4, 694–701 (2003). https://doi.org/10.1038/ni943
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni943
This article is cited by
-
Pro- and anti-inflammatory bioactive lipids imbalance contributes to the pathobiology of autoimmune diseases
European Journal of Clinical Nutrition (2023)
-
HIF1α activation in dendritic cells under sterile conditions promotes an anti-inflammatory phenotype through accumulation of intracellular lipids
Scientific Reports (2020)
-
Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis
The Pharmacogenomics Journal (2017)
-
Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets
Current Allergy and Asthma Reports (2016)
-
Eicosanoid storm in infection and inflammation
Nature Reviews Immunology (2015)